227. オスラー病 Osler disease Clinical trials / Disease details

臨床試験数 : 54 / 薬物数 : 73 - (DrugBank : 21) / 標的遺伝子数 : 23 - 標的パスウェイ数 : 136

1 trial found

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01406639 (ClinicalTrials.gov)	July 2011	29/7/2011	Ranibizumabfor the Management of Recurrent Nosebleeds in Patients With Hereditary Hemorrhagic Telang ...	Ranibizumabfor the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangi ...	Hereditary Hemorrhagic Telangiectasia (HHT);Nosebleeds	Drug: Ranibizumab	University of California, San Diego	Genentech, Inc.	Withdrawn	18 Years	N/A	Both	0	Phase 1	United States

First Previous1Next Last